Could a diabetes pill shield your heart from failure?
NCT ID NCT06507657
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tests whether empagliflozin, a drug originally for diabetes, can improve heart function in 80 adults over 60 with high blood pressure and obesity who are at risk for heart failure. Participants take either the drug or a placebo daily for 9 months, and heart function is measured by ultrasound. The goal is to see if the drug helps the heart's left atrium work better, potentially preventing future heart failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55414, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.